The Valley Desk

ArticleScience advancesPublished

P300/CBP inhibition with inobrodib in combination with gilteritinib and venetoclax targets leukemia stem cells in epigenetic mutant AML

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Thomas Jefferson University, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Science advances
Published
Subject terms
Cell Line, Tumor; Animals; Humans; Mice; Sulfonamides; Aniline Compounds; Imidazoles; Oxazoles; Pyrazines; Epigenesis, Genetic; Mutation; p300-CBP Transcription Factors
PubMed ID
42139346
PubMed Central ID
PMC13178526
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal